TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
Recruiting

Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer

The incidence of breast cancer in Chinese women has increased year by year, and luminal A breast cancer commonly occurs in early-stage and postmenopausal women. This type of breast cancer is not sensitive to chemotherapy, although it has a

Shenyang, Liaoning, China+1 moreView details
CompletedN/A

Evaluation of the SmartBx System for Breast Biopsy

Performance evaluation of a novel, semi-automated device and method for needle core biopsy download compared to standard methods in terms of: 3\. Biopsy core length obtained (i.e.

Afula, North Region, IsraelView details
CompletedN/A

BReast CAncer Genes(BRCA) Expressions in Metastatic Gastric Cancer

The investigators evaluated the incidence of BRCA loss in patients with advanced gastric cancer and observed the treatment outcome and prognosis according to BRCA loss. And the investigators evaluated the possibility of BRCA loss as a predi

Seoul, South KoreaView details
CompletedN/A

Comparative Analysis of Three Locoregional Anesthesia Methods in Breast Tumour Pathology Surgery

The present study compares the Erector Spinae Plane (ESP) block, Pectoral (PECS II) block, and Serratus-Intercostal Fascial Plane (SIFP) block. This is the first article to compare these three locoregional nerve block techniques in acute an

Valencia, Valencia, SpainView details
Completed

Stress, Diurnal Cortisol, and Breast Cancer Survival

The purpose of this study is to learn about the effects of stress on hormones, the relationship between these hormones and cancer progression.

Stanford, California, United StatesView details
UnknownPhase 2

Safety and Efficacy Evaluation of the P2Et Extract in Patients With Breast Cancer

Currently, the study of many extracts in different types of cancer has allowed the validation of scientific knowledge either as a therapy that reduces the size of the tumor or that helps to improve the quality of life of the patient by redu

Bogotá, ColombiaView details
RecruitingPhase 2

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

Breast cancer is not only the leading cause of cancer in women, but also the leading cause of cancer deaths in women. Estrogen receptor-positive and HER2-negative breast cancer is the most prevalent breast cancer subtype.

Chicago, Illinois, United StatesView details
CompletedPhase 1

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations

Visual assessment of diagnostic PET/CT (positron emission tomography/computed tomography) images obtained after a single intravenous injection of BAY86-9596 in patients with cancer and inflammation

Groningen, Provincie Groningen, Netherlands+1 moreView details
CompletedPhase 4

Pulsed Electromagnetic Field Therapy to a Tailored Exercise Program for Patients Suffering From Chemotherapy-induced Neuropathy Related to Breast Cancer

This research studied the usefulness of a targeted intervention designed to manage chemotherapy-induced symptoms, particularly focusing on pain relief, balance deviations and functional improvements. Eighty participants were randomly alloca

Cairo, EgyptView details
Not yet recruitingPhase 3

Oral Paclitaxel + Encequidar vs IV Paclitaxel in Treatment of HER2 Negative Metastatic Breast Cancer

The current study is being conducted to find an optimal Oral Paclitaxel + Encequidar dose and regimen based on prior experience with oral paclitaxel (stage 1) and to compare that dose to an accepted dose and regimen of intravenous (IV) pacl

Multiple locationsView details
TerminatedN/A

Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients

Breast cancer patients are commonly treated with drugs that eggs present in the ovary and may reduce their chance for getting pregnant. Their fertility can be preserved by stimulating their ovaries, collecting multiple eggs, fertilize them

Valhalla, New York, United StatesView details
Recruiting

Assessing Clinical Features and Outcome of Breast Cancer in PALB2 Mutation Carriers: the Palbreast Study

The Modena hereditary breast cancer group identified 3498 BRCA test candidates affected by breast cancer (BC). Among those, 392 were BRCA1/2 positive (11.2%).

Modena, ItalyView details
Active, not recruitingN/A

Together After Cancer

To evaluate the impact of an adapted online, self-help relationship intervention (supplemented with brief coach calls) for survivors of breast cancer and their partners. Couples will be randomized to receive either the online intervention (

Miami, Florida, United States+2 moreView details
UnknownPhase 1 / Phase 2

The Safety and Efficacy of Jobelyn in the Treatment of Breast Cancer Patients

To determine the effective functionality/potency of Jobelyn as an immunologic and haematologic booster in Breast cancer patients (start-off), thus improving the outlook and the quality of life of such patients generally

Ikeja, Lagos, Nigeria+1 moreView details
Unknown

High Risk Breast Cancer Screening Program

Objectives: * To screen population with high risk for breast cancer * To promote the concept and importance of surveillance mammography * To find out the incidence of breast cancer in population who are in high risk for breast cancer * To

Wan Chai, Hong KongView details
CompletedPhase 2

Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer

This phase II study will evaluate and compare the efficacy and tolerability of two dose schedules (1500 mg QD and 500 mg BID) of oral Lapatinib as treatment for patients with advanced or metastatic breast cancer.

Hollywood, Florida, United States+30 moreView details
Unknown

Association of Tumour Grade and Sex Steroid Receptor as a Prognostic Index in Breast Cancer

Null hypothesis: Histological grade of tumour bears no relation with the status of sex hormone receptors. Alternate hypothesis: Both the histological grade of tumour and expression of sex steroid receptors are directly related to each other

Jāmshoro, Sindh, Pakistan+1 moreView details
Recruiting

Implant-based Breast Reconstruction in Post-bariatric Women - a Registry-based National Study

The goal of this national registry-based study is to investigate the prevalence of reconstructive breast surgery and risk factors for surgical complications in women who have had weight loss surgery previously. The main questions it aims to

Gothenburg, SwedenView details
UnknownPhase 2

Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer Patients

Phase II, Open Label, Randomized, Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Subcutaneous (SC) Trastuzumab in Patients with Operable or Locally Advanced /Inflammatory HER2-positive Breast Cancer (ImmunHER)

Cona, Ferrara, Italy+20 moreView details
Active, not recruitingPhase 2

A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation

This study evaluates whether the Potlako+ intervention of community education, clinical provider support, and patient navigation can improve access to cancer case for patients presenting with symptoms of cancer. Half of communities will rec

Gaborone, BotswanaView details
Load more trials